PROM1 and colorectal carcinoma: MZ-CRC-1 cells, which carry the p.M918T RET variant, exhibited higher expression levels of canonical markers, including CD133, DLK1, and multidrug resistance proteins (MRP), compared to TT cells, which harbor the less aggressive p.C634W RET variant.